No Data
No Data
PROCEPT BioRobotics | 10-K/A: Annual report (Amendment)
Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Cuts Target Price to $70
PROCEPT BioRobotics Analyst Ratings
Truist Cuts Price Target on PROCEPT BioRobotics to $70 From $90, Keeps Buy Rating
PROCEPT BioRobotics Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
BTIG Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
Tesla 1st : Agreed